David C Fisher

David C Fisher

UNVERIFIED PROFILE

Are you David C Fisher?   Register this Author

Register author
David C Fisher

David C Fisher

Publications by authors named "David C Fisher"

Are you David C Fisher?   Register this Author

74Publications

1920Reads

45Profile Views

Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study.

Hematol Oncol 2018 Oct 28;36(4):633-637. Epub 2018 Jun 28.

Massachusetts General Hospital Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2515
Publisher Site
http://dx.doi.org/10.1002/hon.2515DOI Listing
October 2018

Revised Dose Ramp-Up to Mitigate the Risk of Tumor Lysis Syndrome When Initiating Venetoclax in Patients With Mantle Cell Lymphoma.

J Clin Oncol 2018 Oct 25:JCO1800359. Epub 2018 Oct 25.

Matthew S. Davids, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Gottfried von Keudell, Yale School of Medicine, New Haven, CT; Craig A. Portell, University of Virginia Health System, Charlottesville, VA; Jonathon B. Cohen, Winship Cancer Institute of Emory University, Atlanta, GA; David C. Fisher, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Francine Foss, Yale School of Medicine, New Haven, CT; Andrew W. Roberts, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia; John F. Seymour, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia; Rod A. Humerickhouse, AbbVie, Chicago, IL; and Constantine S. Tam, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, St Vincent's Hospital, and University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00359
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00359DOI Listing
October 2018

High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.

Sci Transl Med 2018 05;10(440)

Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aar5894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366329PMC
May 2018

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

J Clin Oncol 2017 May 9;35(14):1598-1605. Epub 2017 Jan 9.

Christopher J. Gibson, R. Coleman Lindsley, Brenton G. Mar, Jiantao Shi, Ann S. Lacasce, Arnold S. Freedman, David C. Fisher, Eric Jacobsen, Philippe Armand, Edwin P. Alyea, John Koreth, Vincent Ho, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Sarah Nikiforow, Franziska Michor, and Donna Neuberg, Dana-Farber Cancer Institute; Jiantao Shi and Franziska Michor, Harvard T.H. Chan School of Public Health; Siddhartha Jaiswal, Elizabeth A. Morgan, and Benjamin L. Ebert, Brigham and Women's Hospital, Boston; Benjamin L. Ebert, Broad Institute, Cambridge, MA; Vatche Tchekmedyian, Memorial Sloan Kettering Cancer Center, New York, NY; Alysia Bosworth, Anita Bansal, and Stephen J. Forman, City of Hope National Medical Center, Duarte, CA; and Liton Francisco, Jianbo He, Ravi Bhatia, and Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455707PMC
May 2017

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455688PMC
January 2017

Histopathologic spectrum of hypersensitivity reactions associated with anti-CD52 therapy (alemtuzumab).

J Cutan Pathol 2016 Nov 9;43(11):989-993. Epub 2016 Sep 9.

Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507594PMC
November 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 07 11;30(1):183. Epub 2016 Jul 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.06.008DOI Listing
July 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 04;29(4):574-586

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177991PMC
April 2016

Thyroid lymphoma on a background of Hashimoto's thyroiditis: PET/CT appearances.

Clin Imaging 2014 Nov-Dec;38(6):864-7. Epub 2014 Mar 14.

Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2014.03.004DOI Listing
June 2015

Alemtuzumab therapy for leukemic cutaneous T-cell lymphoma: diffuse erythema as a positive predictor of complete remission.

JAMA Dermatol 2014 Jul;150(7):776-9

Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2013.10099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092049PMC
July 2014

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.

Leuk Lymphoma 2013 Sep 30;54(9):1915-20. Epub 2013 Jan 30.

Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.763397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595907PMC
September 2013

Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir.

JAMA Dermatol 2013 Sep;149(9):1068-70

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2013.5160DOI Listing
September 2013

Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.

Int J Radiat Oncol Biol Phys 2012 May 20;83(1):277-83. Epub 2011 Oct 20.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.05.078DOI Listing
May 2012

Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.

J Clin Oncol 2011 Nov 19;29(31):e772-5. Epub 2011 Sep 19.

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.9967DOI Listing
November 2011

Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.

Clin Cancer Res 2011 May 14;17(9):2977-86. Epub 2011 Mar 14.

Massachusetts General Hospital Cancer Center, Medical Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108904PMC
May 2011

Increased incidence of metopic suture abnormalities in children with positional plagiocephaly.

J Craniofac Surg 2011 Jan;22(1):89-95

Department of Plastic and Reconstructive Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157-1075, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001665-201101000-000
Publisher Site
http://dx.doi.org/10.1097/SCS.0b013e3181f6c5a7DOI Listing
January 2011

Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy.

J Clin Oncol 2010 Mar 16;28(9):1611-5. Epub 2010 Feb 16.

Medical Oncology/Hematology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.3260DOI Listing
March 2010

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Biol Blood Marrow Transplant 2007 Sep 16;13(9):1057-65. Epub 2007 Jul 16.

Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.05.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147857PMC
September 2007

Phase I trial of parathyroid hormone to facilitate stem cell mobilization.

Biol Blood Marrow Transplant 2007 Jul 30;13(7):838-43. Epub 2007 Apr 30.

Hematology/Oncology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910700216
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2007.03.007DOI Listing
July 2007

Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation.

Clin Infect Dis 2005 Dec 8;41(12):e112-4. Epub 2005 Nov 8.

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/498154DOI Listing
December 2005

Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.

Int J Radiat Oncol Biol Phys 2005 Jan;61(1):175-84

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.05.019DOI Listing
January 2005

Unusual sites of Hodgkin's lymphoma: CASE 2. Hodgkin's lymphoma of the CNS masquerading as meningioma.

J Clin Oncol 2004 Oct;22(20):4228-30

Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Brookline, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.01.163DOI Listing
October 2004

Challenging manifestations of malignancies. Case 2. Langerhans cell histiocytosis presenting with a skin rash.

J Clin Oncol 2004 Sep;22(17):3640-2

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2004.02.011
Publisher Site
http://dx.doi.org/10.1200/JCO.2004.02.011DOI Listing
September 2004

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity.

Cancer 2003 Sep;98(5):978-82

James P. Wilmot Cancer Center, University of Rochester, 601 Elmwood Avenue, PO Box 704, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11582DOI Listing
September 2003

Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma.

Int J Radiat Oncol Biol Phys 2002 Mar;52(4):1058-66

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(01)02714-6DOI Listing
March 2002

CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia.

J Immunother (1991) 2001 May;24(3):272-279

Dana Farber Cancer Institute, Boston, Massachusetts; Cedar Sinai Medical Center, Los Angeles, California; University of Iowa Hospitals and Clinics, Iowa City, Iowa; City of Hope National Medical Center, Duarte, California; Mayo Clinic, Rochester, Minnesota; UCLA Medical Center, Los Angeles, California; #Oncology/Hematology Care, University of Cincinnati, Cincinnati, Ohio; Kaiser Permanente, Vallejo, California; Walter Reed Army Medical Center, Washington, DC; New England Medical Center, Boston, Massachusetts, U.S.A.; and Huddinge University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
May 2001